The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prosigna (PAM50) to predict response to neoadjuvant chemotherapy (NAC) in HR+/HER2- early breast cancer (EBC) patients.
 
Begona Jimenez Rodriguez
No Relationships to Disclose
 
Ana Isabel Lavado Fernandez
No Relationships to Disclose
 
Nuria Ribelles
No Relationships to Disclose
 
Pedro Sanchez-Rovira
No Relationships to Disclose
 
Luis Vicioso
No Relationships to Disclose
 
Martina Alvarez
No Relationships to Disclose
 
Vanessa de Luque
No Relationships to Disclose
 
Cesar Ramirez Tortosa
No Relationships to Disclose
 
Wesley Buckingham
Employment - NanoString Technologies
Stock and Other Ownership Interests - NanoString Technologies
Patents, Royalties, Other Intellectual Property - Nanosphere
 
Carl Schaper
Consulting or Advisory Role - Accelerated Medical Diagnostics; Cesca Therapeutics; DiaDexus; Egenomics; Lab21; NanoString Technologies; Siemens
 
Arthur Jeiranian
Employment - NanoString Technologies
 
Naeem Dowidar
Employment - NanoString Technologies
Stock and Other Ownership Interests - NanoString Technologies
 
Sean Ferree
Employment - NanoString Technologies
Stock and Other Ownership Interests - NanoString Technologies
Patents, Royalties, Other Intellectual Property - NanoString Technologies
 
Ester Villar
No Relationships to Disclose
 
Irene Zarcos
No Relationships to Disclose
 
Alfonso Sanchez-Muñoz
No Relationships to Disclose
 
Carlos Gonzalez-Hermoso
No Relationships to Disclose
 
Casilda Llacer Perez
No Relationships to Disclose
 
Aleix Prat
No Relationships to Disclose
 
Emilio Alba
Research Funding - NanoString Technologies (Inst)